PPARG and breast carcinoma: A dose-dependent effect, in which increasing concentrations of LBH589 were monotonically associated with the extent of PPARγ upregulation, was also observed in a variety of representative ER+ and triple-negative (TNBC) breast carcinoma cell lines (Fig. 2D, E).